Aclaris Therapeutics Stock Forecast

Sell candidate since Jan 10, 2025 Loss -12.15%

The Aclaris Therapeutics stock price fell by -1.36% on the last day (Wednesday, 12th Feb 2025) from $2.20 to $2.17. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.98% from a day low at $2.11 to a day high of $2.22. The price has been going up and down for this period, and there has been a -8.05% loss for the last 2 weeks. Volume has increased on the last day by 318 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 717 thousand shares were bought and sold for approximately $1.56 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -32.70% during the next 3 months and, with a 90% probability hold a price between $0.381 and $2.13 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ACRS Signals & Forecast

There are few to no technical positive signals at the moment. The Aclaris Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.39 and $2.52. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 19, 2024, and so far it has fallen -52.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Aclaris Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.05. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.105 between high and low, or 4.98%. For the last week, the stock has had daily average volatility of 6.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACRS) For The Upcoming Trading Day Of Thursday 13th

For the upcoming trading day on Thursday, 13th we expect Aclaris Therapeutics to open at $2.17, and during the day (based on 14 day Average True Range), to move between $1.99 and $2.35, which gives a possible trading interval of +/-$0.180 (+/-8.29%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 16.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.05 (5.53%) than the resistance at $2.48 (14.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aclaris Therapeutics stock A Buy?

Aclaris Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.709 Sell Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on February 13, 2025 - $2.17 ( 0.230%).